SmileDirectClub (NASDAQ: SDC)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-08 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.160 | -0.190 | -0.0300 | ||||
REV | 134.220M | 151.646M | 17.426M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of SmileDirectClub (NASDAQ: SDC) through any online brokerage.
Other companies in SmileDirectClub’s space includes: TELA Bio (NASDAQ:TELA), Chembio Diagnostics (NASDAQ:CEMI), Pulmonx (NASDAQ:LUNG), RxSight (NASDAQ:RXST) and Predictive Oncology (NASDAQ:POAI).
The latest price target for SmileDirectClub (NASDAQ: SDC) was reported by Stifel on Friday, June 17, 2022. The analyst firm set a price target for 1.00 expecting SDC to fall to within 12 months (a possible -7.41% downside). 16 analyst firms have reported ratings in the last year.
The stock price for SmileDirectClub (NASDAQ: SDC) is $1.08 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for SmileDirectClub.
SmileDirectClub’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for SmileDirectClub.
SmileDirectClub is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.